Invesco S&P SmallCap Health Care ETF (PSCH)
187.13
+0.37 (+0.20%)
USD |
Apr 22, 16:59
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.29% | -0.09% | 519.64M | 10974.27 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 0% | 19.00% | -73.58M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600® Capped Health Care Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Invesco |
| Prospectus Benchmark Index | |
| S&P Small 600 Cap HealthCare TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Michael Jeanette | 10.99 yrs |
| Peter Hubbard | 10.99 yrs |
| Tony Seisser | 7.09 yrs |
| Pratik Doshi | 1.28 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
86
-73.58M
-4.178B
Category Low
8.066B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of March 31, 2021
Performance Versus Category
As of April 21, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of April 21, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| NeoGenomics Inc | 5.02% | 49.99 | -2.31% |
| Omnicell Inc | 4.92% | 137.65 | 1.18% |
| Ensign Group Inc | 3.86% | 87.02 | -2.80% |
| Glaukos Corp | 3.48% | 91.77 | 1.32% |
| Select Medical Holdings Corp | 3.35% | 36.70 | -0.86% |
| Conmed Corp | 3.20% | 133.07 | 1.05% |
| AMN Healthcare Services Inc | 3.05% | 78.66 | 2.04% |
| R1 RCM Inc | 2.64% | 26.12 | 1.83% |
| Merit Medical Systems Inc | 2.60% | 62.17 | -1.55% |
| Integer Holdings Corp | 2.59% | 93.05 | -0.65% |
News
Headline
Wire
Time (ET)
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600® Capped Health Care Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Invesco |
| Prospectus Benchmark Index | |
| S&P Small 600 Cap HealthCare TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Michael Jeanette | 10.99 yrs |
| Peter Hubbard | 10.99 yrs |
| Tony Seisser | 7.09 yrs |
| Pratik Doshi | 1.28 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (4-22-21) | 0% |
| 30-Day SEC Yield (3-31-21) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 25.58 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of April 21, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 4/7/2010 |
| Last Annual Report Date | 8/31/2020 |
| Last Prospectus Date | 12/21/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)